| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |